Microwave Ablation Devices Market Report 2025

The microwave ablation devices market size has grown rapidly in recent years. It will grow from $0.42 billion in 2024 to $0.47 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth during the historic period can be attributed to the rising prevalence of cancer, growing demand for minimally invasive procedures, limited efficacy of traditional therapies, increasing incidence of cardiac rhythm disorders, and the expanding application of microwave ablation in treating liver and lung tumors.

The microwave ablation devices market size is expected to see rapid growth in the next few years. It will grow to $0.7 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to the increasing preference for outpatient ablation, improvements in reimbursement policies, rising adoption in emerging markets, a growing geriatric population, and the expanded use of image-guided navigation systems. Major trends during the forecast period include the development of portable and compact devices, the adoption of AI-assisted procedural planning, the advancement of combination therapies involving immunotherapy, and the growing implementation of multi-organ ablation strategies.

The rising incidence of cancer is expected to drive the growth of the microwave ablation devices market in the coming years. Cancer is a condition in which abnormal cells grow uncontrollably and may spread to other parts of the body. The increase in cancer cases is primarily attributed to higher life expectancy, which raises the risk of developing age-related diseases like cancer. Microwave ablation devices are used in cancer treatment by emitting electromagnetic waves that generate heat to destroy tumor cells. This targeted and minimally invasive method helps preserve healthy tissue and enables faster recovery. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental agency, projected that by 2050, there would be over 35 million new cancer cases, a 77% rise compared to the estimated 20 million cases in 2022. As a result, the growing number of cancer cases is contributing to the expansion of the microwave ablation devices market.

Key players in the microwave ablation devices market are focusing on the development of advanced products with regulatory approvals, such as high-precision microwave ablation systems, to enhance outcomes in minimally invasive cancer treatments. These systems use focused microwave energy to precisely destroy tumor tissue while minimizing damage to surrounding healthy structures, thereby improving safety and therapeutic effectiveness. For instance, in January 2024, Hygea Medical Technology Co. Ltd., a China-based medical device manufacturer, received clearance from the U.S. Food and Drug Administration (FDA) for its EXCEED microwave treatment system and EXACT series microwave ablation probe. This followed prior approval from the National Medical Products Administration (NMPA) in China and was achieved through an expedited review. The FDA’s approval confirms the safety, performance, and quality of Hygea’s products for treating solid tumors in soft tissues, marking a significant step in the company’s international market expansion, particularly in the U.S., a key market for microwave ablation technologies. The system complements current cancer therapies by offering a high-precision, minimally invasive thermal ablation option.

In July 2024, Creo Medical Group plc, a UK-based developer of flexible microwave ablation devices, partnered with Intuitive Surgical Inc. to advance the treatment of lung cancer using minimally invasive techniques. This collaboration aims to integrate Creo’s MicroBlate Flex and Kamaptive technology with Intuitive’s Ion Endoluminal System to support expanded clinical research and improve precision in lung cancer diagnosis and ablation across the UK and Europe. Intuitive Surgical Inc. is a US-based leader in minimally invasive care and a pioneer in robotic-assisted surgery.

Major players in the microwave ablation devices market are Johnson & Johnson, Medtronic PLC, Boston Scientific Corporation, Terumo Corporation, Varian Medical Systems, Huber+Suhner, AngioDynamics, BSD Medical Corp., Baird Medical Investment Holdings, Mermaid Medical, Hygea (Beijing) Medical Technology Co. Ltd., Emblation, HS Hospital Service S.p.A., MedWaves Inc., Symple Surgicals, Vision Medical, Canyon Medical Inc., ECO Medical Technology, Irimed Technologies Private Limited, Analytical and Medical Technologies Pvt. Ltd., and Invigor MedKraft.

North America was the largest region in the microwave ablation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in microwave ablation devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the microwave ablation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The microwave ablation devices market consists of revenues earned by entities by providing services such as minimally invasive treatment, localized treatment, support for repeat procedures, and image-guided ablation procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The microwave ablation devices market includes sales of ablation antennas, coaxial cable, control console, and cooling system. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The microwave ablation devices market research report is one of a series of new reports that provides microwave ablation devices market statistics, including the microwave ablation devices industry global market size, regional shares, competitors with the microwave ablation devices market share, detailed microwave ablation devices market segments, market trends, opportunities, and any further data you may need to thrive in the microwave ablation devices industry. This microwave ablation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Microwave ablation (MWA) devices are minimally invasive medical instruments that utilize high-frequency microwave energy to destroy abnormal tissues. These devices generate heat to induce coagulative necrosis, effectively targeting malignant or diseased tissues. This technique offers benefits such as shorter surgical times, minimal damage to surrounding tissues, and quicker patient recovery.

The primary product types of microwave ablation devices include portable wireless ultrasound devices and handheld ultrasound devices. Portable wireless ultrasound devices are compact, wireless imaging tools that offer real-time visualization during procedures, making them suitable for emergency, outpatient, or remote settings. These devices operate using various technologies such as pulsed echo, continuous wave, and thermal ultrasound, with frequency ranges that include low frequency (1-5 megahertz), high frequency (5-15 megahertz), and very high frequency (above 15 megahertz). They are used in a wide range of applications, including oncology, cardiovascular, urology, orthopedic, and others, and are utilized by various end-users such as hospitals, clinics, ambulatory surgical centers, and diagnostic centers.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.